|
At the completion of the clinical evaluation, based on the information received, there were confirmed evidence to support the following reported event.An endoleak type 1a with a secondary procedure (unknown type) was noted.A clinical assessment was required, but no medical information was received.This assessment was based upon the reported event, cumulative knowledge informed by past assessments of similar complaints, and/or other non-medical, relative information such as, but not limited to: still photographs; videos; sizing/case planning sheet/summary cumulative knowledge informed by past assessments of similar complaints was applied to a review of the available medical information.The most likely cause of the loss of seal could not be determined due to lack of relevant medical information.Procedure-related, anatomy-related and user-related issues, off label, or cautionary product use conditions could therefore not be determined.Associated clinical harms for this event included: type ia endoleak and a secondary procedure.The final patient disposition was reported to have no additional negative patient sequelae and patient will be continued to be monitored.This complaint is not capa eligible at this time.The review of manufacturing lot confirmed all devices met specifications prior to release and history shows that no other units from the affected lots have been involved in any similar complaints at this time.The device still remains implanted in the patient and no device will not be returned for evaluation.These types of events will be monitored and trended as part of the quality system.Correction: all manufacturers.
|